Словенија - Словеначки - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

teva pharma b.v. - losartan - filmsko obložena tableta - losartan 91,52 mg / 1 tableta - losartan

Словенија - Словеначки - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

teva pharma b.v. - losartan - filmsko obložena tableta - losartan 91,52 mg / 1 tableta - losartan

Словенија - Словеначки - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

teva pharma b.v. - losartan - filmsko obložena tableta - losartan 45,76 mg / 1 tableta - losartan

Словенија - Словеначки - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

teva pharma b.v. - losartan - filmsko obložena tableta - losartan 91,52 mg / 1 tableta - losartan

Словенија - Словеначки - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

kela nv st -

Европска Унија - Словеначки - EMA (European Medicines Agency)

biontech manufacturing gmbh - single-stranded, 5’-capped messenger rna produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - cepiva - comirnaty 30 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty original/omicron ba. 1 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older who have previously received at least a primary vaccination course against covid-19. comirnaty original/omicron ba. 4-5 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty original/omicron ba. 4-5 (1. 5/1. 5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty omicron xbb. 5 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty omicron xbb. 5 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 10 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. uporaba tega cepiva mora biti v skladu z uradnimi priporočili.

Европска Унија - Словеначки - EMA (European Medicines Agency)

genzyme europe b.v. - alemtuzumab - levkemija, limfocitna, kronična, b-celica - antineoplastična sredstva - zdravilo mabcampath je indicirano za zdravljenje bolnikov s kronično limfocitno levkemijo b (bl), pri katerih kombinirana kemoterapija s fludarabinom ni primerna.

Европска Унија - Словеначки - EMA (European Medicines Agency)

merck sharp & dohme b.v. - doravirine - okužbe z virusom hiv - antivirusi za sistemsko uporabo - pifeltro is indicated, in combination with other antiretroviral medicinal products, for the treatment of adults, and adolescents aged 12 years and older weighing at least 35 kg infected with hiv 1 without past or present evidence of resistance to the nnrti class.

Словенија - Словеначки - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

orodisperzibilna tableta - risperidon

Словенија - Словеначки - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

orodisperzibilna tableta - risperidon